Introduction {#h0}
============

Type IV secretion systems (T4SS) are multiprotein complexes used by Gram-negative and Gram-positive bacteria for transfer of DNA and/or proteins to other bacteria ([@B1]--[@B3]), plants ([@B4]), mammalian cells ([@B5], [@B6]), and yeast cells ([@B7], [@B8]). There are two major classes of T4SS. The first class comprises T4SS involved in conjugative transfer of plasmid DNA between bacteria ([@B1], [@B9]). The second class is involved in pathogenesis by transferring effector proteins into eukaryotic host cells or the extracellular milieu. Human pathogens such as *Helicobacter pylori*, *Legionella pneumophila*, *Bordetella pertussis*, and *Rickettsia prowazekii* require the T4SS for disease ([@B10]).

The canonical model for T4SS is the virulence (*vir*)-induced T4SS of the plant pathogen *Agrobacterium tumefaciens*. *vir*-T4SS delivers both DNA and proteins into plant cells, causing crown gall disease. Components of the *vir*-T4SS are encoded by the tumor-inducing plasmid (pTi). The *vir*-T4SS transports pTi-encoded single-stranded DNA (T strand) and at least four Vir proteins, VirD2, VirE2, VirE3, and VirF, into host cells. Insertion of the T strand into plant genomic DNA and its subsequent expression lead to the overproduction of T-DNA-encoded plant growth hormones, resulting in the tumorous phenotype. Crown gall tumors also produce opines, which are unusual amino acid-derived compounds ([@B11]) specifically catabolized by agrobacteria as a source of carbon and nitrogen, thus providing a selective advantage for their growth in the rhizosphere ([@B12], [@B13]). Strains of *A. tumefaciens* can be differentiated on the basis of the unique opine produced by the tumor, and each type of opine is specifically catabolized by the infecting strain ([@B14]). The two *A. tumefaciens* strains most extensively studied induce tumors that produce nopaline or octopine opines. The *vir*-T4SS components from these two strains are highly conserved ([@B15]).

The *vir*-T4SS is composed of 11 VirB proteins (VirB1 to -11) and VirD4. All VirBs and VirD4 are essential for maximal DNA and protein transport. The *vir-*T4SS components can be placed into three major groups. The first group consists of the T-pilus components and assembly factors VirB1 and VirB3. VirB2 is the major T-pilus structural component, while the minor component, VirB5, is localized at the T-pilus tip ([@B16]). The N-terminal portion of VirB1 has homology to lytic transglycosylases and cleaves the peptidoglycan ([@B17]) to facilitate the assembly of the *vir-*T4SS in the periplasmic space. The C terminus of VirB1, VirB1\*, is secreted to the cell surface ([@B18], [@B19]) and is required for T-pilus formation ([@B20]). VirB3 is also required for T-pilus assembly ([@B21]). The second group consists of VirB6 to VirB10, which span the inner and outer membranes and periplasm, forming the translocation channel ([@B22]). Cryo-electron microscopy and crystal structures show that 14 copies each of VirB7, VirB9, and VirB10 form a 1.05-MDa "core complex" that connects the cytosol to the outer surface of the bacterium with a central core diameter of 76 Å ([@B23], [@B24]). The arrangement of VirB6 and VirB8 with respect to this core is unknown, but both proteins interact with the T strand ([@B25]). The third group consists of VirB4, VirB11, and VirD4, which have ATPase homology and ATP-binding motifs ([@B26]--[@B29]) and may energize assembly and/or substrate translocation. VirD4 is also the coupling protein that brings the T strand and its associated proteins to the *vir*-T4SS ([@B30]--[@B32]).

To understand *vir-*T4SS function, it is critical to determine the localization pattern of the assembled *vir-*T4SS. Previously, we used deconvolution fluorescence microscopy to assess the localization of green fluorescent protein (GFP) fusions to structural components and substrates of the *vir-*T4SS. Due to the bulky nature of GFP, very few fusion proteins were functional; given that many T4SS proteins are multimeric or membrane spanning, GFP fusions are likely to interfere with complex assembly and function. Nevertheless, fusions of GFP to the cytoplasmic tails of VirD4 and VirB8 were functional, and these GFP fusion proteins localized in a helical/periodic pattern of multiple foci around the perimeter of the bacterial cell ([@B33]). However, as there are 12 *vir*-T4SS components, it is possible that there are subassemblies with different localization patterns. Thus, it is critical to determine the localization pattern of the T4SS using probes to all *vir*-T4SS components. Here, we performed immunofluorescence microscopy using antibodies to nine native Vir proteins residing in the inner membrane, periplasm, and outer membrane in the nopaline strain C58 and detected similar patterns of multiple foci supporting our initial findings. In addition, we extended our studies to the octopine strain A348, and the localization of its *vir*-T4SS is identical to that found in the nopaline strain. Fluorescent labeling of the *vir-*T4SS allowed us to examine the orientation of bacteria during binding to plant cells. The majority of bacteria bound laterally along their lengths to plant cells, and multiple *vir*-T4SS foci continued to be present during this binding. These data support a model where multiple *vir-*T4SS around the bacterium maximize effective contact with the host to facilitate efficient transfer of DNA and protein substrates.

RESULTS {#h1}
=======

Nopaline *vir*-T4SS membrane and periplasmic core structural components localize to multiple foci. {#h1.1}
--------------------------------------------------------------------------------------------------

Here we use immunofluorescence followed by deconvolution microscopy to detect nine different structural components of the *vir*-T4SS. The use of antibodies allows localization of the native *vir-*T4SS. In our previous work, GFP fusions to VirB8 and VirD4 and to *vir-*T4SS substrate proteins VirD2, VirE2, and VirF localized to multiple foci in a helical/periodic pattern around the circumference of *vir-*induced cells ([@B33]). Importantly, these fusion proteins did not interfere with tumor formation, and GFP-VirB8 rescued a *virB8* deletion ([@B33]). In contrast, GFP fusions to VirB4, VirB6, VirB7, VirB9, VirB10, and VirB11 exhibited dominant negative effects on tumor formation and did not form multiple foci, suggesting that the GFP fusion interfered with *vir-*T4SS complex assembly and/or function ([@B33]).

Immunofluorescent detection of nopaline strain *vir*-T4SS components VirB1, VirB2, VirB4, VirB5, VirB7, VirB8, VirB9, VirB10, and VirB11 revealed multiple foci ([Fig. 1](#f1){ref-type="fig"}). Ten optical sections were taken for each bacterial cell and then deconvolved to a three-dimensional (3D) image to better resolve the multiple foci ([Fig. 1C](#f1){ref-type="fig"}). The images recapitulate those seen with GFP-VirB8 fusions ([@B33]) and are suggestive of a periodic arrangement of foci. The numbers of foci in the panels in [Fig. 1C](#f1){ref-type="fig"} vary between a minimum of 10 and a maximum of 19.

![Immunofluorescent detection of VirB proteins in *vir-*induced *A. tumefaciens* nopaline strain (C58). *vir*-induced *A. tumefaciens* C58 was probed with primary antibodies to native VirB proteins (α-VirB1, α-VirB2, α-VirB4, α-VirB5, α-VirB7, α-VirB8, α-VirB9, α-VirB10, and α-VirB11) followed by fluorescent secondary antibodies (left to right). (A and B) Bright-field images (A) corresponding to fluorescent panels (B). (C) Maximum-intensity *z* projections of deconvolved *z* stacks of a representative cell.](mbo0051111860001){#f1}

We next analyzed thousands of individual cells to provide a quantitative assessment of the frequency of multiple foci detected by the nine different antibodies to native nopaline *vir*-T4SS components. As it is impractical to perform deconvolution microscopy of stacked optical images of thousands of cells, we instead counted foci in a single plane of focus. We can easily detect multiple foci, and we specifically assessed the frequency of cells exhibiting 3 or more fluorescent foci ([Fig. 1B](#f1){ref-type="fig"}). Over 80% of the cells had 3 or more fluorescently labeled foci ([Table 1](#t1){ref-type="table"}). Most of the cells had between 5 and 10 foci, and a very small percentage of cells had only 3 or 4 foci. For example, the VirB8 antibody detected 3 or more foci in 90% of the fluorescently labeled cells, reinforcing the results seen with GFP-VirB8 in our earlier report ([@B33]). Antibodies to the T-pilus components VirB2 and VirB5 revealed that 92% of the labeled cells had 3 or more foci. In cells labeled with antibodies to the energetic components VirB4 and VirB11, 83 to 85% of the cells contained at least 3 foci. Antibodies to the core components VirB7, VirB9, and VirB10 showed that 85 to 91% of the labeled cells possessed 3 or more foci.

###### 

Cellular localization of VirB proteins

  ------------------------------------------------------------------------
  Strain     Antibody   No. of cells labeled   \% of cells with ≥3 foci\
                                               in one optical section
  ---------- ---------- ---------------------- ---------------------------
  Nopaline   VirB1      504                    94

             VirB2      600                    92

             VirB4      540                    85

             VirB5      450                    92

             VirB7      778                    85

             VirB8      343                    90

             VirB9      94                     91

             VirB10     1,160                  89

             VirB11     315                    83

  Octopine   VirB2      90                     80

  VirB5      145        85                     

             VirB7      159                    72

             VirB8      83                     88
  ------------------------------------------------------------------------

Each antibody labeled significantly more cells (*P* value, \<0.05) of *vir*-induced cultures (+AS) than of noninduced cultures (−AS) ([Table 2](#t2){ref-type="table"}). The majority of antibodies labeled less than 7% of noninduced cells, signifying high specificity of the antibodies ([Table 2](#t2){ref-type="table"}). Antibodies to VirB1 and, to a lesser extent, antibodies to VirB7 were evidently less specific ([Table 2](#t2){ref-type="table"}). Nevertheless, antibodies to VirB1 and VirB7 detected 3 or more foci more frequently in *vir-*induced cells than in noninduced cells, indicating that many of the foci observed in *vir*-induced cells were due to specific antibody binding.

###### 

Labeling specificity of VirB antibodies

  Strain     Antibody[^a^](#ngt2.1)   \% labeled (total no. of cells)   
  ---------- ------------------------ --------------------------------- ------------
  Nopaline   VirB1                    46 (570)                          66 (761)
             VirB2                    4 (1,194)                         45 (1,341)
             VirB4                    2 (752)                           66 (823)
             VirB5                    7 (609)                           69 (654)
             VirB7                    19 (593)                          56 (1,397)
             VirB8                    4 (2,239)                         32 (1,064)
             VirB9                    2 (487)                           8 (1,170)
             VirB10                   2 (2,055)                         29 (3,970)
             VirB11                   5 (265)                           59 (531)
  Octopine   VirB2                    1 (1,380)                         15 (582)
             VirB5                    2 (541)                           63 (229)
             VirB7                    20 (264)                          51 (312)
             VirB8                    0 (555)                           8 (1,081)

 *P* \< 0.05 for all antibodies.

Octopine *vir*-T4SS structural components localize to multiple foci. {#h1.2}
--------------------------------------------------------------------

The *vir*-T4SS components are highly conserved amon*g A. tumefaciens* strains. For example, VirB8 shares 90% amino acid identity between nopaline and octopine strains ([@B15]). VirB8 is a bitopic membrane protein ([@B34]) that accommodates GFP fusions to its short cytoplasmic N-terminal tail without decreased functionality, as previously demonstrated in the nopaline strain ([@B33]). To test the localization of VirB8 in the octopine strain, we made a GFP fusion to the N terminus of octopine VirB8 and monitored its localization using deconvolution microscopy. Indeed, we detected multiple foci localized around the bacterial cell ([Fig. 2](#f2){ref-type="fig"}), resembling the pattern of GFP-VirB8 fluorescence in the nopaline strain ([@B33]).

![Localization of octopine VirB8 in a *vir-*induced *A. tumefaciens* octopine strain (A348). GFP-VirB8 in wild-type A*. tumefaciens* A348. (A) Wide-field image. (B) Maximum-intensity *z* projections of deconvolved *z* stacks of a representative cell. (C) Individual deconvolved slices from top to bottom of the cell in panel B.](mbo0051111860002){#f2}

Antibodies to VirB2, VirB5, VirB7, and VirB8 from the nopaline strain detect *vir*-induced bands of the predicted molecular weights in extracts of the *vir*-induced octopine strain by Western blot analysis ([Fig. 3D](#f3){ref-type="fig"}). Although antibody against nopaline VirB8 detects octopine VirB8 at similar levels, this antibody is not efficient in detecting VirB8 in whole cells by immunofluorescence ([Table 2](#t2){ref-type="table"}). In contrast, while antibodies against nopaline VirB2, VirB5, and VirB7 were less efficient in detecting their octopine homologs on Western blots, these antibodies were effective in detecting their respective proteins in whole cells by immunofluorescence microscopy. Such variation is expected due to the innate complexity of epitope conformations. Antibodies against nopaline T-pilus components VirB2 and VirB5 detected multiple foci in 80% and 85% of the labeled *vir*-induced octopine cells, respectively ([Fig. 3](#f3){ref-type="fig"}; [Table 1](#t1){ref-type="table"}). Similarly, antibodies against the nopaline core components VirB7 and VirB8 detected multiple foci in 72% and 88% of the labeled *vir*-induced octopine cells, respectively ([Fig. 3](#f3){ref-type="fig"}; [Table 1](#t1){ref-type="table"}). Nopaline antibodies against VirB2, VirB5, and VirB8 labeled less than 2% of the octopine cells under noninducing conditions, while VirB7 antibody labeled 20% of noninduced cells ([Table 2](#t2){ref-type="table"}). All antibodies used for immunofluorescence microscopy of the octopine strain showed significantly more labeling in *vir*-induced cells than in noninduced cells (*P* value, \<0.05). In the *vir*-induced cells, over 70% of the labeled cells showed 3 or more foci ([Table 1](#t1){ref-type="table"}).

![Detection of VirB proteins in *A. tumefaciens* A348. Antibodies from the nopaline strain C58 were used to detect native VirB proteins in the octopine strain A348. (A) Bright-field images corresponding to fluorescent panels in panel B. (B and C) Immunofluorescence detection with primary antibodies to native A348 VirB proteins (α-VirB2, α-VirB5, α-VirB7, and α-VirB8) followed by fluorescent secondary antibodies (left to right). (C) Maximum-intensity *z* projections of deconvolved *z* stacks of a representative cell. (D) *A. tumefaciens* bacteria from the nopaline and octopine strains were uninduced (−) or induced with 200 µM AS (+) for the expression of *vir* genes. AS-induced bands of the correct molecular weights were recognized by α-VirB2, α-VirB5, α-VirB7, and α-VirB8.](mbo0051111860003){#f3}

Do T4SS components colocalize? {#h1.3}
------------------------------

Given the multiple foci observed for individual T4SS components, an obvious question is whether such components colocalize to the same foci. Biochemical studies indicate that VirB7-VirB9-VirB10 ([@B24]), VirB4-VirB11 ([@B26]), and VirB4-VirB8 and VirB5-VirB8-VirB10 ([@B35]) copurify. Yeast two-hybrid analyses confirm these interactions and further demonstrate that VirB8 interacts with VirB1, VirB4, and VirB11 and that VirB9 and VirB11 interact ([@B36]). Thus, eight core T4SS components are known to copurify/interact and thus colocalize.

While the T pilus is assumed to localize at the outer limit of the T4SS channel, it is formally possible that the T pilus is a separate entity used only for making host cell contact. We therefore addressed whether a T4SS core component and the VirB2 pilus component colocalize. We detected the T4SS using a GFP-VirB8 fusion and used antibodies to detect VirB2 (red fluorescence). [Figure 4A](#f4){ref-type="fig"} shows two representative cells. Strikingly, there are distinct red and green foci, suggesting that VirB2 and VirB8 do not colocalize; however, there are other orange or greenish yellow foci, suggesting partial colocalization. To the right of each fluorescent cell, we show quantification of the two fluorophores; these plots reinforce the idea that some foci result from colocalized red and green fluorescence and that other foci emit predominantly red or green fluorescence. These data suggest that VirB2 and VirB8 only sometimes colocalize.

![Do T4SS components colocalize? (A) GFP-VirB8 and VirB2 colocalization; VirB2 is detected by primary antibodies to VirB2 and secondary antibodies with red fluorescence (AlexaFluor 546). (B) VirB colocalization with itself detected by GFP-VirB8 and primary antibodies to GFP followed by secondary antibodies with red fluorescence (AlexaFluor 546). Two independent cells are shown in panels A and B. To the right are fluorescent profiles through the regions indicated by the yellow lines in panels A and B; green or red curves indicate GFP or AlexaFluor 546 fluorescence intensity, respectively.](mbo0051111860004){#f4}

As a control for the above, we monitored whether this approach could accurately detect VirB8 colocalization with itself. We detected VirB8 as a GFP fusion and with antibodies to VirB8 (red fluorescence). The upper panel of [Fig. 4B](#f4){ref-type="fig"} shows 3 possible colocalized foci and several foci that do not colocalize. The bottom panel and its tracing reveal excellent colocalization for 3 foci; however, the upper side of the same cell shows a clear red focus indicating no colocalization. Importantly, we expressed GFP-VirB8 in a *virB8* deletion strain, so GFP fluorescence and VirB8 antibodies should detect the same molecule, without any wild-type VirB8 present to compete for antibody binding. We also tested for GFP-VirB8 colocalization using antibodies to VirB8 (red fluorescence) and antibodies to GFP (far-red fluorescence) and obtained similar results that only some foci colocalize (not shown). These data then lead to the unexpected conclusion that combining GFP fusions and immunofluorescence does not reliably result in colocalized foci under these conditions.

Thus, the data testing for VirB2-VirB8 and for VirB8-VirB8 colocalization are similar and do not allow us to conclude that colocalization occurs for all foci. We suggest two likely explanations. First, antibody detection is stochastic; following cell permeabilization and fixation, not all epitopes are in the correct conformation for detection. Second, fixation of cells may lead to unfolding of GFP and stochastic loss of GFP fluorescence.

The above data illustrate the shortcomings of immunofluorescence in resolving protein colocalization in the confines of bacterial cells. These results potentially illuminate why a previous report utilizing immunolocalization found several T4SS components localized to different sites around the bacterial cell ([@B37]).

*A*. *tumefaciens* binds longitudinally to host cells. {#h1.4}
------------------------------------------------------

Attachment between the host cell and *A. tumefaciens* is necessary for the transfer of the *vir-*T4SS substrates and the T-strand complex. Several reports suggested that the *vir*-T4SS localizes to the cell poles ([@B31], [@B32], [@B37]--[@B39]). Earlier reports of a few *A. tumefaciens* bacteria attaching to a single plant cell via their poles lent support for polar attachment ([@B40], [@B41]). Recent reviews continue to suggest polar attachment ([@B42], [@B43]) based on these earlier reports. However, our present and previous findings ([@B33]) demonstrate that *vir-*T4SS components, including T pili, localize around the circumference of the cell, suggesting that there are multiple points of bacterial attachment to host cells. To test if attachment correlates with the localization of the *vir*-T4SS, we used GFP-VirB8 as a marker for the localization of the *vir-*T4SS following incubation of *A. tumefaciens* with plant cells. *A. tumefaciens* carrying a *vir*-inducible GFP-VirB8 plasmid in *trans* to pTi was induced for *vir* gene expression with acetosyringone (AS) prior to incubation with host cells. We used protoplasts of BY2 tobacco culture cells to mimic the wounded cells that *A. tumefaciens* naturally infects and to replicate conditions previously used to monitor attachment ([@B40], [@B41]). Bacteria were incubated with plant protoplasts for 3 h, and binding was monitored by fluorescence deconvolution microscopy. Most bacterial cells bind horizontally along their lengths to the surface of the plant cell ([Fig. 5A and 5B](#f5){ref-type="fig"}). Higher-magnification images again reveal that most bacteria are attached along their length, with few bacteria attaching in a polar fashion ([Fig. 5C and 5D](#f5){ref-type="fig"}); in these latter images, bacteria still contain multiple GFP-VirB8 foci, although their resolution is lower than that shown above ([Fig. 1](#f1){ref-type="fig"}[to](#f2){ref-type="fig"}[3](#f3){ref-type="fig"}), as it is difficult to focus down on spherical plant cells without causing them to burst.

![*A. tumefaciens* attachment to plant protoplasts. (A to D) Incubation of protoplasts with *A. tumefaciens* C58 expressing *vir*-inducible GFP-VirB8. (E and F) Incubation of protoplasts with *A. tumefaciens* C1 lacking the Ti plasmid but expressing GFP under the control of a *lac*-inducible promoter. (G and H) Incubation of protoplasts with *A. tumefaciens* attachment-deficient strain A1020 expressing *vir*-inducible GFP-VirB8. Magnifications: ×600 (A, B, E, F, G, and H) and ×1,000 (C and D). Panels A, C, D, E, and G are GFP epifluorescence. Panels B, F, and H are GFP epifluorescence and bright-field microscopy combined. Bar, 10 µm (A, B, and E to H) or 5 µm (C and D). The insets in panels C and D are shown magnified 2-fold.](mbo0051111860005){#f5}

We performed two control assays to demonstrate that the observed horizontal attachment is biologically relevant. First, we monitored attachment of *A. tumefaciens* lacking the Ti plasmid but expressing an isopropyl-β-[d]{.smallcaps}-thiogalactopyranoside (IPTG)-inducible GFP. Figure 5E and F show no bacteria binding to the protoplasts. Second, we placed *vir*-inducible GFP-VirB8 into attachment-deficient *A. tumefaciens* strain A1020 ([@B41]), and the cells were grown and induced for *vir* gene expression exactly as the wild-type strain was. Figure 5G and H show excellent GFP-VirB8 fluorescence in *vir*-induced A1020, yet none of the cells are attached to the protoplasts.

Thus, wild-type A*. tumefaciens* strains carrying the Ti plasmid bind along their length to plant protoplasts, and *A. tumefaciens* strains lacking the Ti plasmid or defective in plant cell attachment do not bind. The images in [Fig. 5](#f5){ref-type="fig"} are representative of independent experiments, each monitoring hundreds of protoplasts.

DISCUSSION {#h2}
==========

Immunofluorescence deconvolution microscopy revealed that the *A. tumefaciens vir*-T4SS is arranged in multiple foci around the circumference of the bacterial cell, supporting our initial findings with GFP fusions to *vir-*T4SS components VirB8 and VirD4 and substrates VirD2, VirE2, and VirF ([@B33]). Here, we determined the localization of the *vir-*T4SS by monitoring nine of its components (VirB1, VirB2, VirB4, VirB5, VirB7, VirB8, VirB9, VirB10, and VirB11) in the nopaline strain of *A. tumefaciens*. Over 80% of the fluorescently labeled cells in the nopaline strain showed multiple foci around the bacterial cell. Previously, GFP fusions to the ATPases, VirB4 and VirB11, and core components VirB7, VirB9, and VirB10 interfered with tumor formation; therefore, their inability to form multiple GFP foci was not biologically significant ([@B33]). In this report, we used antibodies against these native proteins to perform immunofluorescence microscopy and were now able to determine their localization as multiple foci. The spacing of the *vir-*T4SS foci suggests that they are arranged in a regular pattern. Indeed, an independent quantitative study to theoretically and experimentally assess the pattern of *vir-*T4SS localization supports the idea that *vir*-T4SS are periodically arranged (T. Cameron, M. Roper, and P. Zambryski, unpublished data).

We also extended our localization studies to include VirB1 and T-pilus components VirB2 and VirB5, and all showed similar multifocal localization patterns in whole cells. We did not detect these proteins in extracellular T pili. Thus, our antibodies detected VirB1, VirB2, and VirB5 as native membrane-associated proteins following the mild fixation used for immunofluorescence and also when denatured on Western blots. Different proteins may change conformation in response to chemical treatments and alter the affinity of antigenic epitopes for the primary antibody. Indeed, following harsh chemical fixation and detection via immunogold electron microscopy, the VirB5 antibody detected denatured VirB5 at T-pilus tips, but under these conditions, the VirB2 antibody does not detect cell-bound T pili ([@B16]); these authors used VirB2 and VirB5 antibodies from our lab for their studies. Here, antibodies to VirB1 also labeled a fraction of non-*vir*-induced cells. This nonspecific binding may be due to the recognition of endogenous (non-*vir*) lytic transglycosylases or other epitopes with similarity to the C terminus of the lytic transglycosylase domain of VirB1, the antibody recognition site.

Several authors have observed the localization of *vir*-T4SS components at the bacterial cell poles ([@B31], [@B32], [@B37]--[@B39]). These authors used standard wide-field fluorescence microscopy, where the low signal-to-noise ratio may have obscured other foci present on the cell. Standard wide-field fluorescence microscopy is limited, as it does not give any information in the *z* dimension. In addition, the earlier reports of polar localization of GFP fusions to VirD4, VirE2, VirC1, and VirB6 may result from overexpression of these proteins from the multicopy IncP plasmid. When overexpressed, these proteins would potentially accumulate at the poles in aggregates, as seen in *Escherichia coli* ([@B44]). For example, in the report of polar VirC1, the bacterial cells were misshapen with large bulges at the poles ([@B39]). In contrast, our studies with GFP fusions to Vir proteins did not use multicopy plasmids (33 and this study), and the bacterial cells have the expected rod-shaped morphology.

Notably, multiple foci along the bacterial cell also have been observed for homologs of the *vir*-T4SS proteins, such as the VirB4 homolog TrhC ([@B45], [@B46]) and the VirD4 coupling protein homolog TraG ([@B47]) from the IncH1 conjugative transfer system of *E. coli*. Immunofluorescence studies showed that TrhC and TraG localized at discrete foci around the circumference of the cell membrane.

We previously suggested that the multiple T4SS around the bacterial cell are arranged in a helical pattern ([@B33]) by analogy to bacterial cytoskeletal proteins, such as MreB, proposed to form helical arrays ([@B48]). Two recent reports now characterize MreB localization during cell wall synthesis and suggest that MreB and cell elongation machinery move circumferentially around the cell perpendicular to the length of the cell ([@B49], [@B50]). As *A. tumefaciens* does not contain an MreB homolog ([@B51]), we cannot make direct comparison with these new data and the localization of *vir-*T4SS. It is formally possible that an underlying helical filament is responsible for the anchoring of the *vir-*T4SS. Nevertheless, to be cautious in our interpretation of the data, we suggest that a more accurate description is that the *A. tumefaciens vir-*T4SS localizes in a periodic pattern around the bacterial circumference.

Here we show that *A. tumefaciens* attaches to plant protoplast cells predominantly by making lateral contacts along their sides with few bacteria also attaching via their poles or subpoles. These data suggest that several *vir-*T4SS localized around the bacterial cell may contact the host cell for the transfer of the T strand and the Vir effector proteins. Several previous studies that addressed *A. tumefaciens* binding to plant cells suggested polar attachment ([@B40], [@B41]). There are two significant differences between the earlier reports and the data presented here. First, the early reports detected few bacteria binding to plant cells. In contrast, the use of GFP facilitates the detection of numerous bacteria binding to plant cells along their lengths. Second and more importantly, we used *vir*-induced *A. tumefaciens* to monitor attachment. *vir*-induced *A. tumefaciens* cells are likely primed and ready to attach. Under our conditions, agrobacteria are induced for 48 h at 19°C; this time frame results in maximal labeling of the T4SS ([@B33]). We further suggest that *A. tumefaciens* attachment is likely a stepwise dynamic process. Pole- and subpole-attached *A. tumefaciens* observed here or previously may be in transition to become laterally attached or in transition from detaching from the host cell following transfer of DNA and proteins.

The arrangement of multiple *vir*-T4SS around the bacterial circumference should maximize effective contact between bacteria and host cells. Multiple *vir-*T4SS complexes and lateral attachment points may be required to facilitate efficient transfer of T strands and Vir effector proteins into the host cell ([Fig. 6](#f6){ref-type="fig"}). It is currently estimated that each induced bacterial cell produces 50 T strands ([@B39]). To coat each T strand would require approximately 30 molecules of VirE2 per kilobase of T-DNA ([@B52], [@B53]). Therefore, thousands of VirE2 molecules need to be delivered into the host cytoplasm to prevent T-strand degradation. In addition to the numerous VirE2 molecules, VirE3 and VirF proteins also must be transported through the *vir*-T4SS. Thus, multiple *vir*-T4SS would be advantageous to the bacterial cell to expedite transport of the vast quantities of proteins and T strands as shown in the model in [Fig. 6](#f6){ref-type="fig"}.

![Model for the localization of *vir-*T4SS and lateral attachment of *A. tumefaciens* to a plant cell. It may be advantageous for *A. tumefaciens* to assemble multiple *vir-*T4SS and attach laterally to the host cell to facilitate efficient transfer of the tens of T complexes and thousands of Vir-effector proteins transported through the *vir*-T4SS.](mbo0051111860006){#f6}

MATERIALS AND METHODS {#h3}
=====================

Bacterial strains and growth conditions. {#h3.1}
----------------------------------------

Wild-type A*. tumefaciens* strain C58 contains nopaline pTiC58, and strain A348 contains octopine pTiA6. Strain A1020 carries a Tn*5* insertion at the *chvB* gene and is attachment deficient ([@B41]). For induction of the *vir* system, an overnight culture was diluted to an optical density at 600 nm (OD~600~) of 0.1 in minimal AB medium, pH 5.5, and grown for 5 h at 19°C ([@B18]). Cultures were then plated on AB agar plates with 200 µM acetosyringone (AS) for 2 days at 19°C.

GFP was amplified using iProof DNA polymerase (Bio-Rad, Inc.) according to the manufacturer's instructions. Primers incorporated an NdeI restriction site at the 5′ end of the coding sequence and an SpeI restriction site at the 3′ end. The amplified product was digested with NdeI and SpeI and ligated to similarly digested pSRKGm ([@B54]) to create pJZ210. This strain was induced with 10 mM IPTG at 19°C for 48 h prior to incubation with BY2 protoplasts.

Western analysis. {#h3.2}
-----------------

Proteins from 10^8^ cells were loaded into each lane. After protein separation, gels were transferred to Immobilon-P polyvinylidene difluoride 0.45-µm membranes and analyzed by standard methods for Western blotting.

Immunofluorescence microscopy. {#h3.3}
------------------------------

*vir*-induced cells were fixed in 2.67% paraformaldehyde and 0.01% gluteraldehyde for 15 minutes at room temperature. Cells were washed once in GTE (50 mM glucose, 25 mM Tris, pH 8, 10 mM EDTA), pelleted, resuspended in GTE, and stored overnight at 4°C. Cells were washed in GTE and permeabilized by treatment with 2 mg/ml of lysozyme and 5 mM EDTA for 45 min at room temperature. Primary antibodies were diluted in 1% bovine serum albumin (BSA) in phosphate-buffered saline (PBS): anti-VirB1, anti-VirB2, anti-VirB4, anti-VirB5, and anti-VirB7 were diluted 1:50; anti-VirB8 was diluted 1:200; anti-VirB9 was diluted 1:50; anti-VirB10 and anti-VirB11 were diluted 1:100; and chicken anti-GFP was diluted 1:100 (Aves Labs). Antibodies were added individually to each sample and incubated at 37°C for 60 min. The cells were then washed twice with PBS containing 0.05% Tween 20. The secondary antibodies were diluted in PBS: AlexaFluor 488 and AlexaFluor 546 goat anti-rabbit IgG were diluted 1:250 and AlexaFluor 647 goat anti-chicken IgG was diluted 1:100. Secondary antibodies were added as appropriate, and the samples were incubated at 37°C for 60 min. Cells were washed three times in PBS containing 0.05% Tween 20 and once in PBS. Cells were resuspended in PBS and imaged with an Applied Precision Deltavision Spectris DV4 deconvolution microscope as previously described ([@B33]). To assess colocalization, representative dually labeled cells were chosen from single wide-field images for analysis. Fluorescence profiles were measured in ImageJ (<http://rsbweb.nih.gov/ij>) using the RGB Profiles Tool macro.

*A*. *tumefaciens* interaction with host cells. {#h3.4}
-----------------------------------------------

*A. tumefaciens* C58 containing GFP-VirB8 in *trans* to pTi was grown in AB minimal medium with appropriate antibiotics and induced with 200 µM AS for 48 hours as described above. Bacteria were then scraped off plates and resuspended in AB medium. BY2 tobacco protoplasts were made by treating the culture cells with protoplast enzyme solution (1% cellulase, 0.01% pectolyase, and 0.4 M [d]{.smallcaps}-mannitol) at pH 5.5 for 150 minutes. BY2 protoplasts were collected by centrifugation at 900 × *g* for 5 minutes. BY2 protoplasts were washed twice with ice-cold 0.4 M mannitol and resuspended in protoplast medium (66 mM calcium chloride, 7 mM sodium acetate, 247 mM [d]{.smallcaps}-mannitol, pH 5.8). *A. tumefaciens* was incubated with BY2 protoplasts for 3 h at 19°C. Plant cells were imaged with an Applied Precision Deltavision Spectris DV4 deconvolution microscope.
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